Anumana Receives First and Only FDA Clearance for ECG-AI Cardiac Amyloidosis Algorithm Using a Standard 12-Lead ECG

Patents

Product patents

In accordance with Section 287(a) of Title 35 of the United States Code, the following list identifies Anumana’s rights in U.S. patents associated with the relevant product. This list may be a subset of Anumana’s rights in U.S. patents directed to the relevant product.

ECG-AI® LEF

U.S. Patent No. 12,121,327
U.S. Patent No. 12,201,404
U.S. Patent No. 12,121,326
U.S. Patent No. 12,165,773
U.S. Patent No. 11,972,869
U.S. Patent No. 12,327,638
U.S. Patent No. 12,507,938

ECG-AI® CA

U.S. Patent No. 12,527,512
U.S. Patent No. 12,165,773
U.S. Patent No. 11,972,869
U.S. Patent No. 12,327,638

ECG-AI® PH

U.S. Patent No. 12,340,906
U.S. Patent No. 12,165,773
U.S. Patent No. 11,972,869
U.S. Patent No. 12,327,638
U.S. Patent No. 12,318,205

U.S. Patent No. 12,340,906 U.S. Patent No. 12,165,773 U.S. Patent No. 11,972,869 U.S. Patent No. 12,327,638 U.S. Patent No. 12,318,205